DART Alternatives 2026: AI-Powered Batch Record Review

Pharmaceutical QC teams searching for a DART alternative in 2026 are asking a better question than they were five years ago. The question is no longer "which document management tool should we use?" — it's "how much of our batch review process can AI handle?"

That shift matters. DART (Document Archiving and Retrieval Technology) is a document management system. It stores and retrieves records efficiently. It was not built to read a batch record, understand what it says, flag deviations against manufacturing specifications, or recommend corrective actions. Those capabilities require something fundamentally different.

This article breaks down what DART does well, where it falls short for modern pharmaceutical QC operations, and what to evaluate when selecting an AI-native alternative.

The Core Limitations of DART for Batch Record Review

DART excels at what it was designed to do: organize, store, and surface documents in a compliant, auditable way. For organizations with thousands of documents, that's genuinely valuable. The problem is that batch record review requires more than retrieval.

Manual review still bottlenecks release

In a DART workflow, a QC reviewer logs in, retrieves the batch record, reads it manually, and documents their findings in a separate system. The AI does none of that work. A typical batch record review takes 4–6 hours per batch at mid-size manufacturers. DART doesn't reduce that number — it just makes the document easier to find.

No deviation detection

DART has no understanding of your batch specifications. It cannot compare a recorded temperature reading against the specification range and flag an out-of-spec result. That logic lives in your reviewers' heads, which means review quality depends on attention, experience, and available bandwidth — all of which vary.

Implementation timelines measured in months

A full DART implementation, including validation, user training, and integration with manufacturing systems, typically takes 6–18 months. For small and mid-size manufacturers without a dedicated IT team, that timeline is a significant resource commitment before the system delivers any value.

What Pharma QC Teams Actually Need in 2026

After speaking with QC directors and quality managers across contract manufacturers, specialty pharma, and biotech, the requirements for a DART alternative consistently cluster around four areas:

1. Automated deviation detection

Every batch has specifications. Every batch record has actuals. The core QC job is comparing the two and flagging anything that doesn't match. This is exactly the kind of pattern-matching task that AI handles well — it doesn't get fatigued, doesn't miss a column at 4pm on a Friday, and can process a batch record in minutes rather than hours.

2. Regulatory citation built-in

When a deviation is flagged, the reviewer needs to know which regulatory requirement is implicated. A good AI review tool should automatically cite the relevant sections of 21 CFR, ICH Q10, or applicable compendia standards — not leave that lookup to the reviewer.

3. CAPA recommendations

Identifying a deviation is step one. Recommending a corrective and preventive action is step two. AI trained on pharmaceutical manufacturing data can suggest likely root causes and initial CAPA steps based on the type and severity of the deviation, giving QA the starting point rather than a blank form.

4. Audit-ready output

FDA inspectors look at your batch records. The review documentation that accompanies them needs to show methodology, citations, and a clear decision trail. An AI review system should generate that documentation automatically — not require a QC specialist to reconstruct it after the fact.

ClearBatch vs. DART: Feature Comparison

The table below compares ClearBatch against DART across the dimensions that matter for pharmaceutical batch record review in 2026. For a broader comparison including Veeva Vault QMS, MasterControl, and TrackWise, see the full comparison page.

How AI Changes the Batch Review Workflow

The shift from DART to an AI-native system like ClearBatch isn't just a feature upgrade — it changes the structure of the QC workflow itself.

In a traditional DART workflow, the QC reviewer is the intelligence layer. They read the record, identify issues, look up regulatory requirements, and draft findings. The system is a filing cabinet with search.

In an AI-native workflow, the system performs the first pass: reading the batch record, identifying every out-of-spec result, citing applicable regulations, and generating a preliminary review with recommended actions. The QC reviewer shifts from data reader to decision authority — reviewing AI findings, approving or adjusting recommendations, and signing off on release. The work that remains is higher-value. The manual drudgery is gone.

For a 50-batch-per-week manufacturer, this can represent 200+ hours of reviewer time recaptured monthly. At typical QC specialist rates, that's meaningful cost savings — but the larger benefit is consistency. AI doesn't have bad days, doesn't miss a column under time pressure, and applies the same standard to batch 1 and batch 500.

Evaluating a DART Alternative: What to Ask

If you're actively evaluating systems, these are the questions that separate AI-native batch review tools from document management systems with AI marketing:

• Does the AI read the batch record content, or just index it? Real AI review means understanding specifications, actual values, and whether they match.
• Can it detect out-of-specification results automatically? Ask for a live demo with a batch that has a deviation. How long does detection take?
• Does it cite specific regulatory requirements? "Non-compliant" without a regulatory citation doesn't help you at an inspection.
• What does the audit trail look like? The AI review should be fully traceable — who triggered it, what version of the model ran, what findings it generated.
• How long does validation take? IQ/OQ/PQ documentation should be available. A 30-day deployment target is achievable; 6 months suggests the system wasn't built for regulated environments.

ClearBatch is built to answer yes to all of the above. We designed it specifically for pharmaceutical QC teams who need AI that understands batch records — not a general-purpose document tool with a quality module bolted on. If you want to see it process an actual batch record, the demo does exactly that.